Tuesday, June 06, 2023 1:27:14 PM
1)MOST heavily traded today of ANY
80 mln as of 12 pm when only 3.3 mln out shs! Mkt Cap ~$10 mln MEANS:
2)HUGE NAKED Short Covering!
3)Positive Trial Results:
Hoth Therapeutics Announces Positive Preclinical Results of HT-ALZ treatment for Alzheimer's Disease
PR Newswire - Tue Jun 06, 12:02PM
4)HOTH in Feb hired IntelSelect to investigate Illegal Naked Short Selling:
Hoth Therapeutics Retains ShareIntel to Investigate Illegal Naked Shorting Activity
PR Newswire - Thu Feb 16, 1:35PM
We have been analyzing the stock market and have come up with a list of stocks that we believe are among the most manipulated in the history of the stock market.
The stock market is rigged by a combination of stock exchanges, big Wall Street banks, hedge funds, and market… pic.twitter.com/NuJfACTrY8
— InvestorTurf (@InvestorTurf) April 4, 2023
ADDITIONALLY: Payment for Order Flow
SEC Gary Gensler ~90-95% of retail orders are not processed through the lit exchange..
news.investorturf.com/the-sec-has-th… twitter.com/investorturf/s…
Lit pools, opposite of ‘dark’
en.m.wikipedia.org/wiki/Lit_pool#….
$nwbo Why I believe that NWBO has been the subject of a collusion between market makers and hedge funds to artificially drive the price to levels orders of magnitude below it would be without the manipulation. https://t.co/JhsQ7cFnxC
— Larry Smith (@SmithOnStocks1) June 5, 2023
DIFFERENT STROKES for DIFFERENT FOLKS
Recent HOTH News
- Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024 • PR Newswire (US) • 05/01/2024 12:00:00 PM
- Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds • PR Newswire (US) • 03/27/2024 06:00:00 PM
- Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment • PR Newswire (US) • 03/27/2024 12:27:00 PM
- Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ • PR Newswire (US) • 03/19/2024 12:21:00 PM
- Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio • PR Newswire (US) • 02/29/2024 01:38:00 PM
- Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic • PR Newswire (US) • 02/26/2024 01:11:00 PM
- Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024 • PR Newswire (US) • 02/13/2024 04:45:00 PM
- Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients • PR Newswire (US) • 01/18/2024 01:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 08:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 10:01:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 10:01:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 10:01:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 10:01:05 PM
- Hoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of Miami • PR Newswire (US) • 12/27/2023 01:21:00 PM
- Hoth Therapeutics Announces it Has Successfully Completed Manufacturing of its Cancer fighting HT-KIT for IND-Enabling Studies • PR Newswire (US) • 12/05/2023 01:33:00 PM
- Hoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Development of Hoth's Cancer Fighting HT-KIT • PR Newswire (US) • 11/14/2023 01:37:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:16:03 PM
- Hoth Therapeutics to Present at NobleCon's 19th Annual Emerging Growth Investor Conference, December 3-5, 2023 • PR Newswire (US) • 11/10/2023 01:00:00 PM
- Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug Discovery • PR Newswire (US) • 10/05/2023 02:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 12:15:11 PM
- FDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT, Treatment for Cancer Patients • PR Newswire (US) • 10/02/2023 12:33:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:15:38 PM
- Hoth Therapeutics Announces Closing of $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules • PR Newswire (US) • 09/15/2023 06:38:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/14/2023 09:24:30 PM
- Hoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules • PR Newswire (US) • 09/13/2023 05:43:00 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM